Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:asset_management_company
|
| gptkbp:focus |
gptkb:biotechnology
life sciences companies |
| gptkbp:foundedBy |
gptkb:Marijn_Dekkers
|
| gptkbp:foundedYear |
2017
|
| gptkbp:headquartersLocation |
gptkb:Hampton,_New_Hampshire,_United_States
|
| gptkbp:industry |
life sciences
|
| gptkbp:managingPartner |
gptkb:Marijn_Dekkers
|
| gptkbp:notableInvestment |
gptkb:Ginkgo_Bioworks
gptkb:Casma_Therapeutics gptkb:TCR2_Therapeutics gptkb:23andMe gptkb:Synthego gptkb:Sana_Biotechnology gptkb:Tango_Therapeutics gptkb:AbCellera gptkb:Celsius_Therapeutics gptkb:Element_Biosciences gptkb:Inscripta gptkb:Tessera_Therapeutics gptkb:Tmunity_Therapeutics gptkb:TScan_Therapeutics gptkb:Verve_Therapeutics gptkb:CureVac |
| gptkbp:offers |
venture capital
growth capital |
| gptkbp:website |
https://www.novalislifesciences.com/
|
| gptkbp:bfsParent |
gptkb:Marijn_Dekkers
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
Novalis LifeSciences
|